Small molecule in situ resin capture provides a compound first approach to natural product discovery
- PMID: 38898025
- PMCID: PMC11187115
- DOI: 10.1038/s41467-024-49367-x
Small molecule in situ resin capture provides a compound first approach to natural product discovery
Abstract
Culture-based microbial natural product discovery strategies fail to realize the extraordinary biosynthetic potential detected across earth's microbiomes. Here we introduce Small Molecule In situ Resin Capture (SMIRC), a culture-independent method to obtain natural products directly from the environments in which they are produced. We use SMIRC to capture numerous compounds including two new carbon skeletons that were characterized using NMR and contain structural features that are, to the best of our knowledge, unprecedented among natural products. Applications across diverse marine habitats reveal biome-specific metabolomic signatures and levels of chemical diversity in concordance with sequence-based predictions. Expanded deployments, in situ cultivation, and metagenomics facilitate compound discovery, enhance yields, and link compounds to candidate producing organisms, although microbial community complexity creates challenges for the later. This compound-first approach to natural product discovery provides access to poorly explored chemical space and has implications for drug discovery and the detection of chemically mediated biotic interactions.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Update of
-
Small Molecule in situ Resin Capture - A Compound First Approach to Natural Product Discovery.bioRxiv [Preprint]. 2023 May 30:2023.03.02.530684. doi: 10.1101/2023.03.02.530684. bioRxiv. 2023. Update in: Nat Commun. 2024 Jun 19;15(1):5230. doi: 10.1038/s41467-024-49367-x. PMID: 37398257 Free PMC article. Updated. Preprint.
References
MeSH terms
Substances
Grants and funding
- R21AT010493/U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (NCCIH)
- R01 AI158612/AI/NIAID NIH HHS/United States
- R01AI158612/Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID)
- R21AI171824/DH | NIHR | Efficacy and Mechanism Evaluation Programme (NIHR Efficacy and Mechanism Evaluation Programme)
- R01 GM085770/GM/NIGMS NIH HHS/United States